Breast Cancer Research and Treatment

, Volume 9, Issue 1, pp 5–16 | Cite as

Molecular biology of drug resistance

  • Antonio Fojo
  • Marilyn Cornwell
  • Carol Cardarelli
  • Douglas P. Clark
  • Nancy Richert
  • Ding-wu Shen
  • Kazumitsu Ueda
  • Mark Willingham
  • Michael M. Gottesman
  • Ira Pastan
9th San Antonio Breast Cancer Symposium — Plenary Lecture


adriamycin colchicine drug resistance gene amplification multidrug resistance (mdr) gene P-glycoprotein vinblastine vincristine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Biedler JL, Riehm H: Cellular resistance to actinomycin D in Chinese hamster cellsin vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res 30, 1174–1184, 1970PubMedGoogle Scholar
  2. 2.
    Ling V, Thompson L: Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol 83, 103–116, 1974PubMedGoogle Scholar
  3. 3.
    Juliano RL, Ling V: A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455, 152–162, 1976PubMedGoogle Scholar
  4. 4.
    Beck WT, Mueller TJ, Tanzer LR: Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res 39, 2070–2076, 1979PubMedGoogle Scholar
  5. 5.
    Akiyama S-I, Fojo AT, Hanover JA, Pastan I, Gottesman MM: Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Molec Genet 11, 117–126, 1985PubMedGoogle Scholar
  6. 6.
    Shen D-W, Cardarelli C, Hwang J, Cornwell M, Richert N, Ishii S, Pastan I, Gottesman MM: Multiple drug resistant human KB carcinoma cells independently selected for highlevel resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J Biol Chem 261, 7762–7770, 1986PubMedGoogle Scholar
  7. 7.
    Inaba M, Kobayashi H, Sakurai Y, Johnson RK: Active efflux of daunomycin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res 39, 2200–2203, 1979PubMedGoogle Scholar
  8. 8.
    Fojo AT, Akiyama S-I, Gottesman MM, Pastan I: Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. Cancer Res 45, 3002–3007, 1985PubMedGoogle Scholar
  9. 9.
    Tsuruo T, Iida H, Kitatani Y, Yokota K, Tsukagoshi S, Sakurai Y: Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Cancer Res 44, 4303–4307, 1984PubMedGoogle Scholar
  10. 10.
    Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y: Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res 42, 4730–4733, 1982PubMedGoogle Scholar
  11. 11.
    Fojo AT, Whang-Peng J, Gottesman MM, Pastan I: Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 82, 7661–7665, 1985PubMedGoogle Scholar
  12. 12.
    Federspiel NA, Beverly SM, Schilling JW, Schimke RT: Novel DNA rearrangements are associated with dihydrofolate reductase gene amplification. J Biol Chem 259, 9127–9140, 1984PubMedGoogle Scholar
  13. 13.
    Roninson IB, Abelson HT, Housman DE, Howell N, Varshavski A: Amplification of specific DNA sequences correlates with multidrug resistance in Chinese hamster cells. Nature 309, 626–628, 1984PubMedGoogle Scholar
  14. 14.
    Roninson IB, Chin JE, Choi K, Gros P, Housman DE, Fojo A, Shen D-W, Gottesman MM, Pastan I: Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 83, 4538–4542, 1986PubMedGoogle Scholar
  15. 15.
    Shen D-W, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I, Gottesman MM: Human multidrug-resistant cell lines: increasedmdr1 expression can precede gene amplification. Science 232, 643–645, 1986PubMedGoogle Scholar
  16. 16.
    Shen D-W, Fojo A, Roninson IB, Chin JE, Soffir R, Pastan I, Gottesman MM: Multidrug-resistance in DNA mediated transformants is linked to transfer of the humanmdr1 gene. Mol Cell Biol, 1986, in pressGoogle Scholar
  17. 17.
    Gros P, Ben Neriah Y, Croop JM, Housman DE: Isolation and expression of a cDNA (mdr) that confers multidrug resistance. Nature, 1986, in pressGoogle Scholar
  18. 18.
    Ueda K, Gottesman MM, Pastan I, Roninson IB, Ling V, Riordan J: 1986, in preparationGoogle Scholar
  19. 19.
    Van der Blief AM, Van der Velde-Koerts T, Ling V, Borst P: Overexpression and amplification of five genes in a multidrugresistant Chinese hamster ovary cell line. Mol Cell Biol 6, 1671–1678, 1986PubMedGoogle Scholar
  20. 20.
    Scotto KW, Biedler JL, Melera PW: Amplification and expression of genes associated with multidrug resistance in mammalian cells. Science 232, 751–755, 1986PubMedGoogle Scholar
  21. 21.
    Chen C-J, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB: Internal duplication and homology with bacterial transport proteins in themdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47, 381–389, 1986PubMedGoogle Scholar
  22. 22.
    Ueda K, Clark DP, Roninson IB, Gottesman MM, Pastan I: The human multidrug-resistance (mdr1) gene cDNA cloning and transcription initiation. J Biol Chem, 1987, submittedGoogle Scholar
  23. 23.
    Higgins CF, Hiles ID, Salmond GPC, Gill DR, Downie JA, Evans IJ, Holland IB, Gray L, Buckel SD, Bell AW, Hermodson MA: A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria. Nature 323, 448–450, 1986PubMedGoogle Scholar
  24. 24.
    Higgins CF, Hiles ID, Whalley K, Jamieson DJ: Nucleotide binding by membrane components of bacterial periplasmic binding protein-dependent transport systems. EMBO J 4, 1033–1040, 1985PubMedGoogle Scholar
  25. 25.
    Kartner N, Evernden-Porelle D, Bradley G, Ling V: Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 316, 820–823, 1985PubMedGoogle Scholar
  26. 26.
    Willingham MC, Cornwell MM, Cardarelli CO, Gottesman MM, Pastan I: Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and sensitive KB cells: effect of verapamil and other drugs. Cancer Res, 1986, in pressGoogle Scholar
  27. 27.
    Cornwell MM, Gottesman MM, Pastan I: Increased vinblastine binding to membrane vesicles from multidrug resistant KB cells. J Biol Chem 261, 7921–7928, 1986PubMedGoogle Scholar
  28. 28.
    Cornwell MM, Safa AR, Felsted RL, Gottesman MM, Pastan I: Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150–170 kDa protein detected by photoaffinity labelling. Proc Natl Acad Sci USA 83, 3847–3850, 1986PubMedGoogle Scholar
  29. 29.
    Cornwell MM, Pastan I, Gottesman MM: Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem, 262, 2166–2170 (1987)PubMedGoogle Scholar
  30. 30.
    Akiyama S-I, Cornwell MM, Gottesman MM, Pastan I: Most drugs which reverse multidrug-resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog. Cancer Res 1987, submittedGoogle Scholar
  31. 31.
    Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I: Expression of a multidrug resistance gene in human tumors and tissues. Proc Natl Acad Sci USA, 84, 265–269 (1987)PubMedGoogle Scholar
  32. 32.
    Gottesman MM, Pastan I, Fojo AT, Shen D-W, Ueda K, Clark DP, Cardarelli CO, Richert NE, Willingham M, Cornwell MM: Expression, amplification and transfer of DNA sequences associated with multidrug resistance. Bristol-Meyers Symposium on Cancer Research, 1986, in pressGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers 1987

Authors and Affiliations

  • Antonio Fojo
    • 1
  • Marilyn Cornwell
    • 1
  • Carol Cardarelli
    • 1
  • Douglas P. Clark
    • 1
    • 2
  • Nancy Richert
    • 1
  • Ding-wu Shen
    • 1
  • Kazumitsu Ueda
    • 1
  • Mark Willingham
    • 1
  • Michael M. Gottesman
    • 1
  • Ira Pastan
    • 1
  1. 1.Laboratory of Molecular Biology, National Cancer InstituteNational Institutes of HealthBethesdaUSA
  2. 2.The Howard Hughes Medical InstituteUSA

Personalised recommendations